Brief: Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
26/04/2023 14:27
April 26 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text for Eikon: ID:nGNX7KT7G3
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt